OXFORD BIODYNAMICS LS-,01 Aktie

Oxford BioDynamics has entered into a partnership with the Dubai London Clinics & Hospitals Group (DLCH) to offer the prostate cancer test EpiSwitch PSE across DLCH’s clinic and hospital network in the United Arab Emirates. Patient blood samples will be collected at DLCH facilities and analyzed at Oxford BioDynamics’ laboratory in the UK; the clinical workflow has been validated by both partners. The agreement is the first commercial rollout of the test in the Gulf region; market launch, local market development and collaboration with payers are intended to gradually increase test volumes. » Más en de.investing.com

Oxford BioDynamics raised about £9.15m by placing 9.15 billion new ordinary shares at £0.001 each; after fees roughly £8.4m is expected. The proceeds are intended to fund platform partnerships for EpiSwitch‑Orion, expansion of the prostate cancer test, development of a test for response to checkpoint inhibitors and completion of a colorectal cancer study. Without the financing, cash is expected to be exhausted in early September 2026; the transaction requires shareholder approval (AGM 26 Aug.) and AIM approval (27 Aug.). The company reported a significant capital loss under the Companies Act, and the board is considering alternative financing options, a sale or an orderly wind‑down if the proposal is rejected. » Más en de.investing.com

Oxford BioDynamics has signed a sales agreement with MK Commercial Group to strengthen US distribution of EpiSwitch PSE. Initially seven field sales advisors will be deployed, with the number able to rise to as many as 35 to cover key population centers such as New Jersey, Washington D.C., Virginia, Georgia and Chicago. According to the company, the test for triage after elevated PSA levels has a positive predictive value of 93% and a specificity of 97% and is intended to reduce unnecessary biopsies. The sales representatives will operate under the commercial management of Oxford BioDynamics and will complement the existing sales infrastructure in Frederick, Maryland. » Más en de.investing.com